Concepedia

Hanwu Zhang

HZ

Statistics

Publications

6

Citations

908

H-Index

6

Active since

2017

Affiliations

Shanghai Institute of Materia Medica(Current)

University of Chinese Academy of Sciences

Chinese Academy of Sciences

Hanwu Zhang is an author at Shanghai Institute of Materia Medica specializing in immune checkpoint inhibitors, cancer immunotherapy, and oncology.

Publications per year

2017–2022

6

Publications

6

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

Tingting Wang, Dangge Wang, Haijun Yu et al. · Nature Communications · 2018 · 395 citations · Full text

, , +17

Engineering nanoparticles to locally activate T cells in the tumor microenvironment

Dangge Wang, Tingting Wang, Haijun Yu et al. · Science Immunology · 2019 · 258 citations

, , +17

Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors

Tingting Wang, Dangge Wang, Jianping Liu et al. · Nano Letters · 2017 · 161 citations

, , +17

Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition

Jing Gao, Hanwu Zhang, Fengqi Zhou et al. · Chinese Chemical Letters · 2020 · 41 citations

, , +13

Establishment of a mouse model of lipopolysaccharide‑induced neutrophilic nasal polyps

Shuibin Wang, Hanwu Zhang, Zulian Xi et al. · Experimental and Therapeutic Medicine · 2017 · 28 citations · Full text

, , +17

1–5 of 6